氟伏沙明馬來酸鹽作用機(jī)制 - Medchemexpress - MCE中國_第1頁
氟伏沙明馬來酸鹽作用機(jī)制 - Medchemexpress - MCE中國_第2頁
氟伏沙明馬來酸鹽作用機(jī)制 - Medchemexpress - MCE中國_第3頁
全文預(yù)覽已結(jié)束

氟伏沙明馬來酸鹽作用機(jī)制 - Medchemexpress - MCE中國.docx 免費(fèi)下載

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、Product Data SheetFluvoxamine maleateCat. No.: HY-B0103ACAS No.: 61718-82-9分式: CHFNO分量: 434.41作靶點(diǎn): Serotonin Transporter作通路: Neuronal Signaling儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (230.20 mM)H2O : 20 mg/mL (46.04 mM; Need ultrasonic)* means

2、 soluble, but saturation unknown.SolventMass1 mg 5 mg 10 mgConcentration制備儲(chǔ)備液1 mM 2.3020 mL 11.5099 mL 23.0197 mL5 mM 0.4604 mL 2.3020 mL 4.6039 mL10 mM 0.2302 mL 1.1510 mL 2.3020 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液的保存式和期限:-80C, 6 months; -20C, 1 month。-80C 儲(chǔ)存時(shí),請?jiān)?6 個(gè)內(nèi)使,-20C

3、儲(chǔ)存時(shí),請?jiān)?1 個(gè)內(nèi)使。體內(nèi)實(shí)驗(yàn)請根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍?。以下溶解案都請先按?In Vitro 式配制澄清的儲(chǔ)備液,再依次添加助溶劑:為保證實(shí)驗(yàn)結(jié)果的可靠性,澄 的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使; 以下溶劑前顯的百分 指該溶劑在您配制終溶液中的體積占;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的式助溶1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.75 mM); Clear solution此案可獲得 2.

4、5 mg/mL (5.75 mM,飽和度未知) 的澄清溶液。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 400 L PEG300 中,混合均勻;向上述體系中加50 L Tween-80,混合均勻;然后繼續(xù)加 450 L 理鹽定容 1 mL。2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (5.75 mM); Clear solutionPage 1 of 2 www.MedChemE此案可獲得 2.5 mg/mL (5.75 mM,飽和度未知) 的澄清溶液

5、。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 900 L 20% 的 SBE-CD 理鹽溶液中,混合均勻。3. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (5.75 mM); Clear solution此案可獲得 2.5 mg/mL (5.75 mM,飽和度未知) 的澄 溶液,此案不適于實(shí)驗(yàn)周 期在半個(gè)以上的實(shí)驗(yàn)。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 900 L 油中,混合均勻。4. 請依序添加每種溶劑: PBS5.Solubil

6、ity: 20 mg/mL (46.04 mM); Clear solution; Need ultrasonic請依序添加每種溶劑: phosphate buffer salineSolubility: 20 mg/mL (46.04 mM); Clear solution; Need ultrasonicBIOLOGICAL ACTIVITY物活性 Fluvoxamine maleate (DU-23000 maleate)5-羥胺再吸收抑制劑,有抗抑郁活性。IC & Target SSRIs1.體內(nèi)研究 Fluvoxamine maleate (DU-23000 maleate) is

7、effective in inhibiting 5-ht uptake by blood platelets and brainsynaptosomes. The antagonism by fluvoxamine of the reserpine-induced lowering of the pentamethylenetetrazoleconvulsive threshold can be regarded as due to an effect upon 5-HT uptake. In contrast to the effects ofdesmethylimipramine and

8、imipramine, no stimulatory effects are found in rats when rapidly acting reserpine-likecompounds are given following a dose of fluvoxamine1. Fluvoxamine (DU-23000) appears to improve combat-related PTSD symptoms but not depressive symptoms. The high attrition rate and lack of a placebo group limits

9、theconclusions of our study. Controlled studies of fluvoxamine in the treatment of PTSD are warranted2. Fluvoxamine(DU-23000) was less potent at decreasing ethanol self-administration when food was available concurrently versuswhen ethanol was available in isolation ED50: 4.0 (2.7-5.9) and 5.1 (4.3-

10、6.0). Effects on food were similar under eachcondition in which food was available. The results demonstrate that the potency of fluvoxamine in reducing ethanol-maintained behavior depends on whether ethanol is available in isolation or in the context of concurrently scheduledfood reinforcement3.戶使本產(chǎn)

11、品發(fā)表的科研獻(xiàn) Sci Transl Med. 2019 Feb 6;11(478). pii: eaau5266. PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007681.See more customer validations on HYPERLINK www.MedChemE www.MedChemEREFERENCES1. Ginsburg, B.C., J.W. Pinkston, and R.J. Lamb, The potency of fluvoxamine to reduce ethanol self-administration de

12、creases with concurrent availability offood. Behav Pharmacol, 2012. 23(2): p. 134-42.2. Claassen, V., et al., Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol, 1977. 60(4): p. 505-16.3. Escalona, R., et al., Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. Depress Anxiety, 2002. 15(1): p. 29-33.Page 2 of 3 www.MedChemEMcePdfHeightCaution: Product has not b

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論